A citation-based method for searching scientific literature

Bruce G Haffty, David M Euhus, Lori J Pierce. J Clin Oncol 2020
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Interpretation of breast cancer screening guideline for Chinese women.
Yubei Huang, Zhongsheng Tong, Kexin Chen, Ying Wang, Peifang Liu, Lin Gu, Juntian Liu, Jinpu Yu, Fengju Song, Wenhua Zhao,[...]. Cancer Biol Med 2019
6
50

Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women.
Julie R Palmer, Eric C Polley, Chunling Hu, Esther M John, Christopher Haiman, Steven N Hart, Mia Gaudet, Tuya Pal, Hoda Anton-Culver, Amy Trentham-Dietz,[...]. J Natl Cancer Inst 2020
21
50

Prognostic and Predictive Implications of PTEN in Breast Cancer: Unfulfilled Promises but Intriguing Perspectives.
Luisa Carbognin, Federica Miglietta, Ida Paris, Maria Vittoria Dieci. Cancers (Basel) 2019
26
50


Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care.
Patricia Ashton-Prolla, Juliana Giacomazzi, Aishameriane V Schmidt, Fernanda L Roth, Edenir I Palmero, Luciane Kalakun, Ernestina S Aguiar, Susana M Moreira, Erica Batassini, Vanessa Belo-Reyes,[...]. BMC Cancer 2009
40
50

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
50

Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study.
Nichola Johnson, Olivia Fletcher, Cristina Naceur-Lombardelli, Isabel dos Santos Silva, Alan Ashworth, Julian Peto. Lancet 2005
63
50

Dramatic response to PARP inhibition in a PALB2-mutated breast cancer: moving beyond BRCA.
T Grellety, F Peyraud, N Sevenet, O Tredan, N Dohollou, E Barouk-Simonet, M Kind, M Longy, J-Y Blay, A Italiano. Ann Oncol 2020
11
50

Breast cancer risk in neurofibromatosis type 1 is a function of the type of NF1 gene mutation: a new genotype-phenotype correlation.
Ian M Frayling, Victor-Felix Mautner, Rick van Minkelen, Roope A Kallionpaa, Safiye Aktaş, Diana Baralle, Shay Ben-Shachar, Alison Callaway, Harriet Cox, Diana M Eccles,[...]. J Med Genet 2019
15
50


Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers.
Brian Drohan, Constance A Roche, James C Cusack, Kevin S Hughes. Ann Surg Oncol 2012
58
50


PTEN Expression as a Complementary Biomarker for Mismatch Repair Testing in Breast Cancer.
Gianluca Lopez, Marianna Noale, Chiara Corti, Gabriella Gaudioso, Elham Sajjadi, Konstantinos Venetis, Donatella Gambini, Letterio Runza, Jole Costanza, Chiara Pesenti,[...]. Int J Mol Sci 2020
10
50

Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis.
Xuan-Anh Phi, Sepideh Saadatmand, Geertruida H De Bock, Ellen Warner, Francesco Sardanelli, Martin O Leach, Christopher C Riedl, Isabelle Trop, Maartje J Hooning, Rodica Mandel,[...]. Br J Cancer 2016
45
50

Consortium piecing together role of ATM gene in breast cancer.
Elizabeth Finkel. J Natl Cancer Inst 2002
2
50

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Fergus J Couch, Hermela Shimelis, Chunling Hu, Steven N Hart, Eric C Polley, Jie Na, Emily Hallberg, Raymond Moore, Abigail Thomas, Jenna Lilyquist,[...]. JAMA Oncol 2017
290
50

TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines.
Ashkan Shahbandi, Hoang D Nguyen, James G Jackson. Trends Cancer 2020
13
50

Risk assessment, screening and prevention of breast cancer: A look at cost-effectiveness.
Gail S Lebovic, Alan Hollingsworth, Stephen A Feig. Breast 2010
10
50

Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined.
Eveline A M Heijnsdijk, Ellen Warner, Fiona J Gilbert, Madeleine M A Tilanus-Linthorst, Gareth Evans, Petrina A Causer, Rosalind A Eeles, Reinie Kaas, Gerrit Draisma, Elizabeth A Ramsay,[...]. Cancer Epidemiol Biomarkers Prev 2012
51
50

Clinical spectrum and prognostic value of TP53 mutations in circulating tumor DNA from breast cancer patients in China.
Zongbi Yi, Fei Ma, Guohua Rong, Yanfang Guan, Chunxiao Li, Binghe Xu. Cancer Commun (Lond) 2020
9
50

A Critical Review of the Quality of Cough Clinical Practice Guidelines.
Mei Jiang, Wei-Jie Guan, Zhang-Fu Fang, Yan-Qing Xie, Jia-Xing Xie, Hao Chen, Dang Wei, Ke-Fang Lai, Nan-Shan Zhong. Chest 2016
30
50

Quality assessment of cancer cachexia clinical practice guidelines.
Wang-Qin Shen, Liang Yao, Xiao-Qin Wang, Yan Hu, Zhao-Xiang Bian. Cancer Treat Rev 2018
11
50

MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
Sepideh Saadatmand, H Amarens Geuzinge, Emiel J T Rutgers, Ritse M Mann, Diderick B W de Roy van Zuidewijn, Harmien M Zonderland, Rob A E M Tollenaar, Marc B I Lobbes, Margreet G E M Ausems, Martijne van 't Riet,[...]. Lancet Oncol 2019
43
50

Breast cancer risks and risk prediction models.
Christoph Engel, Christine Fischer. Breast Care (Basel) 2015
31
50

An update on breast cancer screening and prevention.
Maria Syl D de la Cruz, Mona Sarfaty, Richard C Wender. Prim Care 2014
9
50

Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients.
Xuan Wang, Neng Wang, Lidan Zhong, Shengqi Wang, Yifeng Zheng, Bowen Yang, Juping Zhang, Yi Lin, Zhiyu Wang. Mol Psychiatry 2020
23
50


The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2018 Edition.
Takayoshi Uematsu, Kazutaka Nakashima, Mari Kikuchi, Kazunori Kubota, Akihiko Suzuki, Shogo Nakano, Kouichi Hirokaga, Ken Yamaguchi, Shigehira Saji, Hiroji Iwata. Breast Cancer 2020
6
50

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
50

Evaluation of the Utility of Screening Mammography for High-Risk Women Undergoing Screening Breast MR Imaging.
Glen Lo, Anabel M Scaranelo, Hana Aboras, Sandeep Ghai, Supriya Kulkarni, Rachel Fleming, Karina Bukhanov, Pavel Crystal. Radiology 2017
33
50

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
502
50

Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.
Kate E Roberts, Kirsty Rickett, Sophie Feng, Dimitrios Vagenas, Natasha E Woodward. Cochrane Database Syst Rev 2020
12
50

Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.
Jonine L Bernstein, Robert W Haile, Marilyn Stovall, John D Boice, Roy E Shore, Bryan Langholz, Duncan C Thomas, Leslie Bernstein, Charles F Lynch, Jorgen H Olsen,[...]. J Natl Cancer Inst 2010
88
50

RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells.
Xiaosong Yang, You Pan, Zhaojun Qiu, Zhanwen Du, Yao Zhang, Pengyan Fa, Shashank Gorityala, Shanhuai Ma, Shunqiang Li, Ceshi Chen,[...]. Clin Cancer Res 2018
19
50

Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians.
Cecelia A Bellcross, Katherine Kolor, Katrina A B Goddard, Ralph J Coates, Michele Reyes, Muin J Khoury. Am J Prev Med 2011
113
50

Knowledge, attitudes and behavior of physicians regarding predictive genetic tests for breast and colorectal cancer.
Carolina Marzuillo, Corrado De Vito, Stefania Boccia, Maddalena D'Addario, Elvira D'Andrea, Paola Santini, Antonio Boccia, Paolo Villari. Prev Med 2013
35
50

Recommendations on prevention and screening for breast cancer in Hong Kong.
T H Lam, K H Wong, K Kl Chan, M Cm Chan, D Vk Chao, A Ny Cheung, C Ym Fan, J Ho, E P Hui, K O Lam,[...]. Hong Kong Med J 2018
4
50

Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK).
Anouk Pijpe, Nadine Andrieu, Douglas F Easton, Ausrele Kesminiene, Elisabeth Cardis, Catherine Noguès, Marion Gauthier-Villars, Christine Lasset, Jean-Pierre Fricker, Susan Peock,[...]. BMJ 2012
113
50

Surveillance of Women with the BRCA1 or BRCA2 Mutation by Using Biannual Automated Breast US, MR Imaging, and Mammography.
Jan C M van Zelst, Roel D M Mus, Gwendolyn Woldringh, Matthieu J C M Rutten, Peter Bult, Suzan Vreemann, Mathijn de Jong, Nico Karssemeijer, Nicoline Hoogerbrugge, Ritse M Mann. Radiology 2017
38
50

GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines.
Pablo Alonso-Coello, Andrew D Oxman, Jenny Moberg, Romina Brignardello-Petersen, Elie A Akl, Marina Davoli, Shaun Treweek, Reem A Mustafa, Per O Vandvik, Joerg Meerpohl,[...]. BMJ 2016
311
50

Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines.
Holger J Schünemann, Donata Lerda, Cecily Quinn, Markus Follmann, Pablo Alonso-Coello, Paolo Giorgi Rossi, Annette Lebeau, Lennarth Nyström, Mireille Broeders, Lydia Ioannidou-Mouzaka,[...]. Ann Intern Med 2020
52
50

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
50

A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO.
D G R Evans, D M Eccles, N Rahman, K Young, M Bulman, E Amir, A Shenton, A Howell, F Lalloo. J Med Genet 2004
182
50

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer.
Achim Wöckel, Jasmin Festl, Tanja Stüber, Katharina Brust, Stephanie Stangl, Peter U Heuschmann, Ute-Susann Albert, Wilfried Budach, Markus Follmann, Wolfgang Janni,[...]. Geburtshilfe Frauenheilkd 2018
29
50

Rare variants in the ATM gene and risk of breast cancer.
David E Goldgar, Sue Healey, James G Dowty, Leonard Da Silva, Xiaoqing Chen, Amanda B Spurdle, Mary Beth Terry, Mary J Daly, Saundra M Buys, Melissa C Southey,[...]. Breast Cancer Res 2011
127
50

ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3).
Shani Paluch-Shimon, Olivia Pagani, Ann H Partridge, Omalkhair Abulkhair, Maria-João Cardoso, Rebecca Alexandra Dent, Karen Gelmon, Oreste Gentilini, Nadia Harbeck, Anita Margulies,[...]. Breast 2017
136
50

Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation.
A Salmon, D Amikam, N Sodha, S Davidson, L Basel-Vanagaite, R A Eeles, D Abeliovich, T Peretz. Clin Oncol (R Coll Radiol) 2007
44
50


Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood.
S J Kony, F de Vathaire, A Chompret, A Shamsaldim, E Grimaud, M A Raquin, O Oberlin, L Brugières, J Feunteun, F Eschwège,[...]. Lancet 1997
111
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.